Vaccine Info

Nimenrix Meningococcal ACW-135Y Vaccine

Nimenrix Meningococcal ACW-135Y Description

Nimenrix contains Neisseria meningitidis serogroup A polysaccharide, 5 µg; Neisseria meningitidis serogroup C polysaccharide, 5 µg; Neisseria meningitidis serogroup W-135 polysaccharide, 5 µg; Neisseria meningitidis serogroup Y polysaccharide, 5 µg, conjugated to tetanus toxoid carrier protein of 44 µg.

Nimenrix Meningococcal ACW-135Y Vaccine Indication

Nimenrix is indicated for the active immunization of individuals from 6 weeks to 55 years of age against invasive meningococcal diseases caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

Nimenrix Meningococcal ACW-135Y Vaccine Dosage

Nimenrix is for intramuscular injection only.

Nimenrix Meningococcal ACW-135Y Vaccine News

 

Updated
08/27/2020 - 09:48